Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index L

Labels
drug: Sec. 2, Ch. 6
food: Sec. 2, Ch. 5
Lactose intolerance: Sec. 1, Ch. 2
Lactulose
in constipation: Sec. 3, Ch. 55
Language: (see also Speech)
in dementia: Sec. 3, Ch. 27
perception of: Sec. 1, Ch. 2
Large intestine
biopsy of: Sec. 3, Ch. 51
cancer of: (see also Colorectal cancer)
     screening for: Sec. 2, Ch. 10
colonoscopy of: Sec. 2, Ch. 10; Sec. 2, Ch. 10; Sec. 2, Ch. 10; Sec. 3, Ch. 51
herniation of: Sec. 3, Ch. 59
ischemia of: Sec. 3, Ch. 55
perforation of: Sec. 2, Ch. 10
polyps of: Sec. 3, Ch. 51
surgery (colostomy) of: Sec. 3, Ch. 51; Sec. 3, Ch. 55; Sec. 3, Ch. 51
Laryngitis: Sec. 3, Ch. 38
Larynx: Sec. 3, Ch. 38
cancer of: Sec. 3, Ch. 38
dryness of: Sec. 3, Ch. 38
Laser therapy
in age-related macular degeneration: Sec. 3, Ch. 36
in diabetic retinopathy: Sec. 3, Ch. 36
in glaucoma: Sec. 3, Ch. 36
in rosacea: Sec. 3, Ch. 35
in varicose veins: Sec. 3, Ch. 44
Laxative
before colonoscopy: Sec. 2, Ch. 10; Sec. 2, Ch. 10
Laxatives: Sec. 3, Ch. 55; Sec. 3, Ch. 55
habitual use of: Sec. 3 Ch. 55 [sidebar]
undernutrition and: Sec. 3 Ch. 17 [detail]
Learned helplessness: Sec. 2, Ch. 13
Leflunomide: Sec. 3, Ch. 41
Leg
abnormal movements of: Sec. 3, Ch. 31
amputation of: Sec. 2, Ch. 13
     problems after: Sec. 2, Ch. 13
arterial (vascular) disease of: Sec. 3, Ch. 44; Sec. 3, Ch. 44
artificial: Sec. 2, Ch. 13
brace for: Sec. 2, Ch. 13; Sec. 2, Ch. 13
claudication in: Sec. 3, Ch. 34
     in atherosclerosis: Sec. 3, Ch. 44
     in peripheral arterial disease: Sec. 3, Ch. 44; Sec. 3, Ch. 60
superficial thrombophlebitis of: Sec. 3, Ch. 44; Sec. 3, Ch. 49
swelling in: Sec. 3, Ch. 18
swelling of
     in deep vein thrombosis: Sec. 3, Ch. 44
ulcers of
     in diabetes: Sec. 3, Ch. 34; Sec. 3, Ch. 34
     venous: Sec. 3, Ch. 35; Sec. 3, Ch. 44
varicose veins of: Sec. 3, Ch. 35; Sec. 3, Ch. 44
Legal issues: Sec. 4, Ch. 65
Legionella pneumophila infection: Sec. 3, Ch. 52
Legionnaires' disease: Sec. 3, Ch. 52
Lens
artificial: Sec. 3, Ch. 36
cloudiness of (cataract): Sec. 3, Ch. 36; Sec. 3, Ch. 20
Lepirudin: Sec. 3 Ch. 49 [sidebar]
Leukemia
bleeding in: Sec. 3, Ch. 50
chronic lymphocytic (CLL): Sec. 3, Ch. 51
information resources on: 883
polycythemia vera and: Sec. 3, Ch. 49
Leukocyte esterase: Sec. 3, Ch. 56
Leukocytes: (see White blood cells)
Leukotriene receptor blockers
in allergic rhinitis: Sec. 3, Ch. 38
Leuprolide: Sec. 3, Ch. 51
Levodopa
in dystonia: Sec. 3, Ch. 30
in Parkinson's disease: Sec. 3, Ch. 30; Sec. 3, Ch. 30
Lewy body dementia: Sec. 3, Ch. 27
Libido (sex drive)
female: Sec. 3, Ch. 58
male: Sec. 1, Ch. 2
License
driving: Sec. 4, Ch. 62
Licensed practical nurse: Sec. 2, Ch. 9
Lichen planus
mouth sores in: Sec. 3, Ch. 39
of vulva: Sec. 3, Ch. 58
Lichen sclerosus: Sec. 3, Ch. 58
Licorice: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7; Sec. 2, Ch. 7
Lidocaine
in abnormal heart rhythms: Sec. 3, Ch. 47
in postherpetic neuralgia: Sec. 3, Ch. 29
Life expectancy: Sec. 1, Ch. 1; Sec. 1, Ch. 3; Sec. 1, Ch. 3
Life-care community (continuing care retirement community): Sec. 2, Ch. 9; Sec. 2, Ch. 14; Sec. 2, Ch. 14
Life-long learning: Sec. 4, Ch. 61
Lifestyle
changes in: Sec. 2, Ch. 4
in heart disorders: Sec. 2, Ch. 13
healthy: Sec. 2, Ch. 4
Ligaments
aging of: Sec. 1, Ch. 2
Light
for reading: Sec. 1, Ch. 2; Sec. 1, Ch. 2; Sec. 3, Ch. 36
sensitivity to: Sec. 1, Ch. 2
Lightheadedness: Sec. 3, Ch. 20
on standing: Sec. 3, Ch. 20; Sec. 3, Ch. 20
Lip reading: Sec. 3, Ch. 37
Lipids: (see Fat; Lipoproteins)
Lipoprotein synthesis inhibitor: Sec. 3, Ch. 44
Lipoproteins
in coronary artery disease: Sec. 3, Ch. 45
desirable level of: Sec. 3, Ch. 44
garlic and: Sec. 2, Ch. 7
stroke and: Sec. 3 Ch. 28 [detail]
Lisinopril
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Lithium
hypothyroidism with: Sec. 3, Ch. 33; Sec. 3, Ch. 33
Lithotripsy
in gout: Sec. 3, Ch. 41
Liver
acetaminophen effects on: Sec. 3, Ch. 24
aging of: Sec. 1, Ch. 1; Sec. 1, Ch. 2
disorders of
     cancer treatment and: Sec. 3, Ch. 50
     in myelofibrosis: Sec. 3, Ch. 49
drug processing by: Sec. 2, Ch. 6
failure of
     flapping tremor with: Sec. 3, Ch. 30
Living alone: Sec. 4, Ch. 61
undernutrition and: Sec. 3 Ch. 17 [detail]
Living arrangements
changes in: Sec. 4, Ch. 61
of older Americans: Sec. 1, Ch. 3; Sec. 2, Ch. 14
relocation and: Sec. 4, Ch. 61
Living longer
strategies for: Sec. 1 Ch. 1 [sidebar]
Living will: Sec. 2, Ch. 12; Sec. 2, Ch. 16; Sec. 4, Ch. 65
Local anesthesia: Sec. 2, Ch. 12
Long-term care facility: Sec. 2, Ch. 14; Sec. 2, Ch. 9 (see also Nursing homes)
for dementia patient: Sec. 3, Ch. 27
after surgery: Sec. 2, Ch. 14
Long-term relationships: Sec. 4, Ch. 63
Loperamide: Sec. 3, Ch. 55
Lorazepam: Sec. 2, Ch. 6; Sec. 3, Ch. 32
urinary incontinence with: Sec. 3, Ch. 57
Losartan
in coronary artery disease: Sec. 3, Ch. 45
in heart failure: Sec. 3, Ch. 46
in high blood pressure: Sec. 3, Ch. 43
Lotions
for dry skin: Sec. 3, Ch. 35
Lou Gehrig's disease (amyotrophic lateral sclerosis)
swallowing difficulty in: Sec. 3, Ch. 54
Lovastatin: Sec. 3, Ch. 44
in coronary artery disease: Sec. 3, Ch. 45; Sec. 3, Ch. 45
Low blood pressure
in anemia: Sec. 3, Ch. 49
after eating (postprandial): Sec. 3, Ch. 20; Sec. 3, Ch. 20
fainting with: Sec. 3, Ch. 20; Sec. 3, Ch. 20
falls and: Sec. 3 Ch. 21 [detail]
after heart attack: Sec. 3, Ch. 45
with hip fracture: Sec. 3, Ch. 23
orthostatic
     tilt table for: Sec. 2, Ch. 13
on standing (orthostatic): Sec. 3, Ch. 20; Sec. 3, Ch. 20
     falls and: Sec. 3 Ch. 21 [detail]
     in Shy-Drager syndrome: Sec. 3, Ch. 30; Sec. 3, Ch. 30
     testing for: Sec. 3, Ch. 20
     treatment of: Sec. 3, Ch. 20
after surgery: Sec. 2, Ch. 12
Low-vision aids: Sec. 3 Ch. 36 [sidebar]
Loxapine: Sec. 3, Ch. 32
Lumbar puncture: (see Spinal tap)
Lump
in breast: Sec. 3, Ch. 51; Sec. 3, Ch. 51
Lumpectomy: Sec. 3, Ch. 51; Sec. 3, Ch. 51
Lung scan: Sec. 2, Ch. 10; Sec. 3, Ch. 44
Lungs
abnormal sounds in: Sec. 3, Ch. 52; Sec. 3, Ch. 53
aging of: Sec. 1, Ch. 2
bed rest effects on: Sec. 2, Ch. 11
cancer of: Sec. 3, Ch. 51
defense mechanisms of: Sec. 3, Ch. 52
disorders of
     dizziness with: Sec. 3, Ch. 20
     exercise in: Sec. 3, Ch. 60
     heart failure and: Sec. 3 Ch. 46 [detail]
     information resources on: 889
fluid accumulation in: Sec. 3, Ch. 45; Sec. 3, Ch. 46; Sec. 3, Ch. 46
infection of: Sec. 3, Ch. 52
obstructive disease of: Sec. 3, Ch. 53 (see also Chronic obstructive pulmonary disease [COPD])
scan of: Sec. 3, Ch. 44
Lupus anticoagulant: Sec. 3, Ch. 49
Lupus
mouth sores in: Sec. 3, Ch. 39
Lyme disease
dementia with: Sec. 3 Ch. 27 [sidebar]
Lymph nodes
in breast cancer: Sec. 3, Ch. 51; Sec. 3, Ch. 51; Sec. 3, Ch. 51
in cancer: Sec. 3, Ch. 50
in chronic lymphocytic leukemia: Sec. 3, Ch. 51
Lymphocytic leukemia
chronic (CLL): Sec. 3, Ch. 51
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.